Now first of all I do appreciate I am being a hypocrite here as I am on record a stating nobody here as a clue what will happen and nobody has ever got anything right before, except unfortunately for the bashers..
But putting that to one side and swallowing a bit of pride I'm asking is there anyone here who thinks ,barring unexpected news like partnership etc, that this could run up to say $1.50 - $2.00 over the next 2-3 months?....after all we have seen it happen to untold other biotechs on little or no news many of whom did not even have a drug in P3..
So, for those who understand these things more than I do, can read charts etc, is it likely to happen, or is it more likely will be stuck at these levels for a good while now..
Thank you for your observations which I highly appreciate. I am as puzzled as you are. I would think this stock is in better shape than RNN (which has no drug in P3 but has run strongly from under $1). Given the time it takes to conduct a P3 (12-18 months), any news would be toward the end of this year and more likely next. The only reason I can think of in the next 2-3 months is if the stock becomes a market favorite, but that is such a fickle sentiment it's almost impossible to time. As somebody who has a small long position in this stock and is under water, the only thing I can do given the science which I think is encouraging is to basically wait. I know this is not much but it is the only explanation I have. And no, you are not a hypocrite. I have been reading your posts and respect your views. Stay safe.
It is possible but in my opinion not within 2-3 months. I am saying that because if you take any stock, its price rise according to news, trends etc. With this particular stock, I honestly unable to analyze it. I am here for 6 months now more or less and I have no explanation of how this company conducts itself. One thing i can tell you for sure this stock today with its current pipeline with all the news so far should cost around 5 dollars solid. Believe you me Brendan, the only reason Glycometetics cost 15 dollars a share is because of the partnership with Pfitzer. I don't know whether this stock is manipulated or something is getting built up, one thing i can tell you for sure there is a huge chance for partnership hands down but again the question is when? but when it happens i can guarantee you the price per share will "(should)" be higher than Glycometetics today. I personally believe that if partnership announced it will be with Novartis just because too much coincidence between Aires and them. I swear to you that i am not trying to pump or bash the stock but since I have invested here i would like to see this growing and whatever i told you is what i feel.
Hi mark, thanks for your comments...you say ''I am saying that because if you take any stock, its price rise according to news, trends etc'' but that's not always true is it, as I said in my OP some biotechs have run on little or no news...in fact many of them have..but it never happens here.